Trials / Unknown
UnknownNCT05049083
A Relative Bioavailability Study of Different Processes of SHR2554 Tablets in Healthy Adult Subjects
A Single-centre, Single-dose, Random, Open, Two-period, Cross-over Relative Bioavailability Study of Different Processes of SHR2554 Tablets in Healthy Adult Subjects
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 28 (actual)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
TThe study is being conducted to evaluate the relative bioavailability, pharmacokinetics and safety of different tablet processes of SHR2554 in healthy adult subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | New Process SHR2554 tablet、Former Process SHR2554 tablet | New Process, 350 mg SHR2554 tablets on study day 1 - Former Process, 350 mg SHR2554 tablets on study day 8 |
| DRUG | Former Process SHR2554 tablet、New Process SHR2554 tablet | Former Process, 350 mg SHR2554 tablets on study day 1 - New Process, 350 mg SHR2554 tablets on study day 8 |
Timeline
- Start date
- 2021-12-17
- Primary completion
- 2022-01-06
- Completion
- 2022-04-29
- First posted
- 2021-09-17
- Last updated
- 2022-01-14
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05049083. Inclusion in this directory is not an endorsement.